ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,442.00
2.14%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,232.44
0.55%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Gamida Cell Ltd (GMDA) Quote

Gamida Cell Ltd

Gamida Cell Ltd (GMDA)

NASDAQ
0.0327
0.00
(0.00%)
Closed May 03 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.0327
Bid
0.0302
Ask
0.0304
Volume
-
0.00 Day's Range 0.00
0.0303 52 Week Range 2.51
Market Cap
3.979M
Previous Close
0.0327
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
12,736,104
Shares Outstanding
132,638,514
Dividend Yield
-
PE Ratio
-0.06
Earnings Per Share (EPS)
-0.47
Revenue
1.78M
Net Profit
-63M

About Gamida Cell Ltd

Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the lif... Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the life-saving benefits of hematopoietic stem cell transplant. It is also developing GDA-201 which is innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma. It is developing a diverse pipeline of cell therapies using its proprietary NAM technology that has the potential to bring life-saving treatment options to patients. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.gamida-cell.com
Headquarters
Jerusalem, Jerusalem, Isr
Founded
1970
Gamida Cell Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker GMDA. The last closing price for Gamida Cell was $0.03. Over the last year, Gamida Cell shares have traded in a share price range of $ 0.0303 to $ 2.51.

Gamida Cell currently has 132,638,514 shares outstanding. The market capitalization of Gamida Cell is $3.98 million. Gamida Cell has a price to earnings ratio (PE ratio) of -0.06.

GMDA Latest News

More News

XORTX Welcomes New Member to the Board of Directors

CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical...

April 08 2024
GlobeNewswire Inc.

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

April 01 2024
GlobeNewswire Inc.

U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading

U.S. index futures indicate an uptrend in pre-market trading on Wednesday, bouncing back after a previous unfavorable session that further distanced the indices from reaching their record levels...

March 27 2024
IH Market News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4-0.0068-17.21518987340.03950.03950.032221056280.0327CS
12-0.3451-91.34462678670.37780.4310.0303127361040.08619278CS
26-0.6573-95.26086956520.690.860.030369895620.17108381CS
52-1.5773-97.96894409941.612.510.030340836260.50312001CS
156-7.3873-99.55929919147.427.430.030319994791.11885631CS
260-7.8373-99.5844980947.87150.030313009251.75010229CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.17M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
Chromosome Chromosome 4 minutes ago
Yes NS, I did…..and?
AMRN
SSKILLZ1 SSKILLZ1 5 minutes ago
VMIR

The VMIR is Up +1.68%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.

The 77 Original Stocks ($1,000.00)
[pre]
Symbol Value Of Investment
ACCO $802.63
AESI $1,27
AMRX ARMN BBW
SSKILLZ1 SSKILLZ1 5 minutes ago
VMIR

The VMIR is Up +1.68%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.

The 77 Original Stocks ($1,000.00)
[pre]
Symbol Value Of Investment
ACCO $802.63
AESI $1,27
AMRX ARMN BBW
koolmc koolmc 5 minutes ago
lol
SPZI
NASDAQ2020 NASDAQ2020 5 minutes ago
HammerTime !!
GME
Shekiboy Shekiboy 6 minutes ago
A drunk ‘dr’ posting on a trash site about his/her superior ways in trash OTC…

Go to bed ‘dr’ Drano. You have a sewer to deal with tomorrow. The ‘anesthesia’ is no match for the methane as you know.


Just too easy.
SPZI
JohnnyHydrogen JohnnyHydrogen 6 minutes ago
Theoretically, a company will sell shares at a high price, for the overall benefit of the company and shareholders. They may even release news or other things to drive the price up beforehand.

Realistically, many companies will do the exact opposite. That is, they sell shares at the
FCEL
rbtree rbtree 6 minutes ago
Delta Dawn becomes Drowsy Don

https://youtu.be/dDv2w8jUGrw?si=czomekUY1nWEgHh-
DJT
XMaster2023 XMaster2023 6 minutes ago
That’s because she is worth it!
NWBO
koolmc koolmc 7 minutes ago
possible get's past 19's will fuel it. if you check the charts it's spikes just as hard as it drops.
GME
DewDiligence DewDiligence 8 minutes ago
AMGN contends that they couldn’t give out more details about the phase-2 MariTide trial because they have to “protect the integrity of the trial,” which is still blinded to patients and investigators. However, this claim does not entirely ring true; merely disclosing (as AMGN did) that the efficacy
AMGN
Dubbie1 Dubbie1 9 minutes ago
Just gotta merge into this shell and it's kaboom!!
LICH
RMS555 RMS555 9 minutes ago
I was tired of waiting for merger news and when it finally came it didnt do much.

Also I sold because of the pumpers on this board, they've been saying a certain number for years and dont have any real DD to value the company at their predicted price.... I also doubt that those certa
BLLB
Kansasjack1 Kansasjack1 9 minutes ago
Woohoo!! That is Great News!!
Maybe over the weekend? We might some news by Monday? Go FBEC!!!!!!!!!!
FBEC
weedtrader420 weedtrader420 9 minutes ago
BITCOIN SHIBADOGE BONK BONK ROCKY - GO THE DISTANCE
BTCUSD
SitTight SitTight 10 minutes ago
Actually, Merck's patent expired in 2017, and there are 3 generics.
Merck’s patent expired in March 2017, and three companies have since been granted approval by the FDA to produce generic versions: Fresenius Kabi USA (for the US), Gland Pharma Ltd, and Mylan Labs Ltd.
https://www.aspe
IPIX
delerious1 delerious1 10 minutes ago
Well sorry you're going to miss the fun
MJNA
johnydollar johnydollar 11 minutes ago
Yeah, they have so much love ,their families are sick of it.......

It's just overflowing on us.....

They probably should start selling it at QVC ........

Can you imagine if we got 100% guarantee love..........

😆 🤣 😂
DBMM
OMOLIVES OMOLIVES 12 minutes ago
By the way...everyone in Boston is sweating their asses of currently..lol. They'll probably get it...but I am Team Canada all the way. Oilers first :)
RedSox04 RedSox04 12 minutes ago
Moon
MWWC
delerious1 delerious1 12 minutes ago
"delerious1" is a name...and granted should have a capital D....therefore it is not spelled wrong since it is a name....it's a name not a word...get it???

You brought it up...don't shoot the messenger
IGPK
SSKILLZ1 SSKILLZ1 12 minutes ago
VMI/VMIR Differential Chart
[pre]
VMI VMIR Differential
1/5/2024 -1.04% -1.04% 0.00%
1/12/2024 -2.63% -2.63% 0.00%
1/19/2024 -3.07% -3.07% 0.00%
1/26/2024 -0.64% -0.64% 0.00%
2/2/2024 -2.47% -2.14% 0.33%
2/9/2024 -2.
SSKILLZ1 SSKILLZ1 12 minutes ago
VMI/VMIR Differential Chart
[pre]
VMI VMIR Differential
1/5/2024 -1.04% -1.04% 0.00%
1/12/2024 -2.63% -2.63% 0.00%
1/19/2024 -3.07% -3.07% 0.00%
1/26/2024 -0.64% -0.64% 0.00%
2/2/2024 -2.47% -2.14% 0.33%
2/9/2024 -2.
imafan imafan 12 minutes ago
Coming from a professed liar! Rich, very Rich! Real News, HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES Lurking!
HHSE
Saving Grace Saving Grace 12 minutes ago
Count on it. Short selling banks that aren't Basil III compliant are going insolvent.
GME

Your Recent History

NASDAQ
GMDA
Gamida Cell
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved